30
Jan

Pfizer is walking away from a $70 million collaboration with Waltham, MA’s Repligen, handing back some early-stage treatments for the rare spinal muscular atrophy.

…read more

Source: Pfizer bails on a $70M rare disease deal with Repligen

    

0 No comments